Novabay Pharmaceuticals Inc

-0.02 (-1.13%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)3.46M
Current PEN/A
Forward PE N/A
2yr Forward PE 21.25
See more stats
Estimates Current Quarter
Revenue$4.23 Million
Adjusted EPS-$0.27
See more estimates
10-Day MA$1.64
50-Day MA$2.03
200-Day MA$4.44
See more pivots

Novabay Pharmaceuticals Inc Stock, ASE:NBY

2000 Powell Street, Suite 1150, Emeryville, California 94608-1866
United States of America
Phone: +1.510.899.8800
Number of Employees: 31


NovaBay Pharmaceuticals, Inc. engages in the development and sales of scientifically-created and clinically-proven eyecare and skincare. Its products include Avenova, NeutroPhase, CelleRx, and DERMAdoctor. The company was founded by Ramin Najafi on January 19, 2000 and is headquartered in Emeryville, CA.